Publications by authors named "A E Haberl"
Background: Women with HIV are globally underrepresented in clinical research. Existing studies often focus on reproductive outcomes, seldom focus on older women, and are often underpowered to assess sex/gender differences. We describe CD4, HIV viral load (VL), clinical characteristics, comorbidity burden, and use of antiretroviral therapy (ART) among women with HIV in the RESPOND study and compare them with those of the men in RESPOND.
View Article and Find Full Text PDFIntroduction: Antiretroviral therapy (ART) is integral to HIV prevention, including averting vertical transmission. The World Health Organization (WHO) recommends ART and breastfeeding for all women living with HIV for at least 12 months post-partum [1, 2]. Much of the data on HIV transmission through breastfeeding comes from low-resource settings, with a paucity of data on breastfeeding-related HIV transmission in women living with HIV in other settings.
View Article and Find Full Text PDFIncidence of anal carcinoma (AC) in people living with HIV (PLWH) is increased compared to the general population. Adverse effects of chemoradiotherapy (CRT) on the immune system are associated with a significant detrimental prognosis on overall survival in patients receiving CRT for solid tumors. The aim of this study was to evaluate immunological factors, in particular the differences in recovery of CD4 and CD8 cell counts before and after CRT for AC in PLWH.
View Article and Find Full Text PDFArticle Synopsis
- The study examined the impact of government-funded pre-exposure prophylaxis (PrEP) on sexually transmitted infections (STIs) among people living with HIV, specifically in men who have sex with men, after PrEP became covered by German health insurance in September 2019.
- Researchers enrolled 143 patients diagnosed with STIs over two groups: one year before and one year after PrEP coverage, noting an increase in STIs, particularly syphilis and chlamydia, in the latter group.
- The findings suggest a trend of rising STI rates among people living with HIV following the introduction of PrEP coverage, highlighting the need for increased discussions about STI risks between these overlapping communities.